BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6437362)

  • 1. [Behavior of PaO2 after intravenous administration of reproterol in subjects with chronic obstructive bronchopneumopathy].
    Grandillo F; Giunta R; Grassia A; Cacciapuoti F; Nappo V; Varricchio M
    Arch Monaldi; 1983; 38(5-6):201-8. PubMed ID: 6437362
    [No Abstract]   [Full Text] [Related]  

  • 2. [The hemodynamic effects of reproterol in patients with chronic obstructive lung disease (author's transl)].
    Bonaduce D; Ferrara N; Canonico V; Cocozza M; Petretta M; Romano E; Rengo F
    G Ital Cardiol; 1981; 11(10):1467-71. PubMed ID: 7341317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation using dynamic ECG of the effects of reproterol (a new beta-2 adrenergic receptor agonist) on the heart conduction system].
    Citone C; Carelli M; Di Marcotullio G; Tubaro M; Milazzotto F
    Clin Ter; 1984 Sep; 110(5):429-36. PubMed ID: 6149836
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacodynamic aspects of reproterol].
    Marmo E
    Clin Ter; 1981 Sep; 98(5):481-500. PubMed ID: 7307450
    [No Abstract]   [Full Text] [Related]  

  • 5. [A multi-centre study of reproterol, a bronchodilator (author's transl)].
    Nolte D; Galgóczy G; Lode H; Mándi A; Matthys H; Stresemann E
    Dtsch Med Wochenschr; 1977 Apr; 102(16):619-23. PubMed ID: 856569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of reproterol on ciliary beat frequency of human bronchial epithelium in vitro.
    Hesse H; Kasparek R; Mizera W; Unterholzner C; Konietzko N
    Arzneimittelforschung; 1981; 31(4):716-8. PubMed ID: 7195718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of reproterol upon tracheo- bronchial, cardiac and cerebral adenylcyclase.
    Marmo E; DiMezza F; Giordano L; Scognamiglio M; Pentimalli D; Marfella A
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):389-95. PubMed ID: 6123142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
    Hermann R; Ruus P; Schneider E; de Mey C
    Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of reproterol in patients with obstructive pathology of the airways].
    Puzio E; Montanero F; Mosca L; Caserta L; Russo V
    Clin Ter; 1985 Jan; 112(2):141-4. PubMed ID: 3893858
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction.
    Macha HN; Aurich R
    Arzneimittelforschung; 1982; 32(7):774-6. PubMed ID: 6751338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of methacholine-induced bronchoconstriction with reproterol, a new beta agonist-xanthine derivative.
    Klaustermeyer WB; Kuhn GJ; Santiago SM; Wehiky I; Hunt EJ
    Ann Allergy; 1981 Apr; 46(4):189-92. PubMed ID: 7011112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of bronchodilator agents on gaseous enchange in the lungs].
    Ciappi G; Orlandelli E; Valente S; Damato S; Pagliari G
    Recenti Prog Med; 1974 Jan; 56(1):77-92. PubMed ID: 4406416
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of theophylline on tcPO2 in adults with chronic lung disease.
    Nauth HF; Börngen U; Huch R; Huch A
    Birth Defects Orig Artic Ser; 1979; 15(4):541-7. PubMed ID: 534738
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of oral salbutamol with reproterol in reversible airway obstruction.
    Dubey GR; Dabholkar SV; Kamat SR; Mahashur AA; Shah SP; Sonaje AG; Athawale SS
    J Assoc Physicians India; 1986 Mar; 34(3):179-82. PubMed ID: 3525508
    [No Abstract]   [Full Text] [Related]  

  • 15. [Orciprenaline and theophylline effect on the circulatory system during ergometer stress].
    Meier G; Schümann R
    Med Klin; 1969 Apr; 64(15):689-92. PubMed ID: 5783030
    [No Abstract]   [Full Text] [Related]  

  • 16. Reproterol--A monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma.
    Juergens UR; Stöber M; Vetter H
    Respiration; 1999; 66(3):220-4. PubMed ID: 10364737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect and tolerance of intravenous reproterol in infants and children].
    Camprag D; Dovat V; Bogdanov B; Conkić B; Tabori D; Aurich R
    Med Welt; 1979 Jun; 30(23):897-901. PubMed ID: 459809
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic effect of bronchospasmin in bronchial asthma patients].
    Kosturkov G; Staneva M; Vŭlcheva T; Mileva Zh; Gaĭtandzhiev K
    Vutr Boles; 1983; 22(4):46-9. PubMed ID: 6372247
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of antigen-induced bronchoconstriction with reproterol, a new beta agonist-xanthine derivative.
    Kuhn GJ; Weliky I; Santiago SM; Klaustermeyer WB
    Ann Allergy; 1981 Apr; 46(4):193-6. PubMed ID: 7011113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative respiratory therapy: bronchospasmolytic activity and side-effects of some recently introduced beta-sympatheticomimetic agents (author's transl)].
    Brandl M; Beer S; Hamer P
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):197-202. PubMed ID: 7027819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.